MedTrace Logo

Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults

NCT06323889 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-12-20

No results posted yet for this study

Summary

LIMITFOOD2 is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of obese adults. A total of 90 participants will be randomized into three equally sized groups: a modified alternate day fasting, a time-restricted eating and a control group, receiving general weight-loss counseling.

Conditions

  • Intermittent Fasting
  • Obesity
  • Time Restricted Eating

Interventions

BEHAVIORAL

Modified Alternate Day Fasting

Participants are instructed to fast every other day.

BEHAVIORAL

Time-Restricted Eating

Participants are instructed to limit food intake to two main meals consumed in maximum 8 hours per day

BEHAVIORAL

Weight-loss counseling

Participants will receive nutrition counseling to structure their main meals according to the plate model for weight-loss and to reduce number of consumed plates.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Philipp Gerber, MD · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-23
Primary Completion
2026-09-30
Completion
2027-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06323889 on ClinicalTrials.gov